GEN Exclusives

More »

GEN News Highlights

More »
Jan 25, 2007

Roskamp Institute Discovers New Class of Drugs for Alzheimer's Disease

  • The Roskamp Institute discovered a new class of drugs that lowers the production of the main pathological protein that causes Alzheimer's disease.

    The discovery is detailed in an article co-authored by Daniel Paris, senior scientist, and Michael Mullan, M.D., Ph.D., director of the institute, appearing in Neuroscience Letters. They report that NF-kB, already known for its role in inflammation, also stops the production of B-amyloid.

    "Although we have known about the important inflammatory role of NF-kB for a long time, we did not know that it controls B-amyloid production," remarks Dr. Paris. "This may be one way that the inflammation caused by B-amyloid leads to more B-amyloid being produced—a positive feedback loop with awful consequences for the sufferer."

    Dr. Mullan notes that the discovery gives “many companies working on NF-kB inhibitors the opportunity to test these types of drugs in Alzheimer's."



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?